Iran Press/ Iran News: The 3rd phase of the clinical trial of the COVID-19 vaccine of Razi Vaccine and Serum Research Institute began on Sunday with the permission of the Research Ethics Committee of the Ministry of Health and Medical Education of Iran.
In today’s ceremony, held in the presence of the Minister of Agriculture Jihad Javad Sadatinejad, 150 volunteers received the first dose of the vaccine as the 3rd phase began. 21 days later the volunteers will get their second dose and 30 days later they will get their inhaled dose.
Razi COV-Pars coronavirus vaccine, which is made of recombinant protein, is used both by inhalation and injection.
By: Neda Sajadi
Read More:
Iran: COVID-19 kills 515 people in 24 hrs
Biggest COVID-19 vaccine consignment arrives Iran
Necessary arrangements need for fair distribution of vaccines
